William H. Rastetter, Director at Regulus Therapeutics Inc. (RGLS), bought 250,000 shares at $1.15 ($288K) on 2017-03-07, disclosed to the SEC on 2017-03-07.
Open-market purchase of $288k RGLS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| Filing → |
| NBIX | SELL | 2024-08-16 | $4.2M | — | Filing → |
| NBIX | SELL | 2024-01-04 | $2.9M | — | Filing → |
| NBIX | SELL | 2023-05-03 | $872K | — | Filing → |